Flavonoids and Chronic Liver Diseases

Mechanisms of Action against NAFLD/NASH and Liver Fibrosis Chronic liver diseases (CLDs)—ranging from steatosis to fibrosis and cirrhosis—remain a clinical challenge due to the limited availability of effective and well-tolerated treatments. A review published in Molecules (March 11, 2025) compiles preclinical evidence on three key natural compounds: baicalein, galangin, and isorhamnetin. The underlying theme is…